Loading...

215 posters, 5 topics, 22 sessions, 596 authors, 283 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Obstetric Anaesthesia Annual Scientific Meeting 2025

May 15 - 16, 2025 | ICC, 2 Lanyon Place, Belfast BT1 3WH

Obstetric Anaesthesia Annual Scientific Meeting 2025 banner

6779422

A case report of a parturient with supraventricular tachycardia intrapartum.

Part of Topic

Case report

Case

A 21-year-old (G1P0), presented for induction of labour at 42 weeks due to large gestational age (>97% centile, 4.8kg). During the second stage of labour she developed a spontaneous supraventricular tachycardia (SVT) requiring medical management.

•The patient had a heart rate of 202bpm, a blood pressure of 117/61 and was asymptomatic.
•12-lead ECG confirmed atrioventricular nodal re-entry tachycardia (AVNRT) (Photo 1). Vagal manoeuvres including carotid sinus massage and Valsalva were attempted without response.
•Adenosine (6mg) was administered and AVNRT converted to sinus rhythm (Photo 2).
•The patient subsequently required Kielland’s rotational forceps delivery under a spinal anaesthetic. APGAR scores at 1 and 5 minutes were 8 and 9 respectively.
•Bloods were unremarkable other than a magnesium of 0.62mmol/L (Normal range 0.7 – 1.0mmol/L). Transthoracic echocardiogram 3 days postnatal revealed a mildly dilated left ventricle with normal function. Cardiology follow-up was arranged.

Discussion

Tachyarrhythmia’s may manifest for the first time during pregnancy. Paroxysmal SVT (22-33 per 100,000 pregnancies) [1] is one of the most common arrhythmias after AF and premature beats. In a haemodynamically stable patient, vagal manoeuvres and adenosine are recommended.

Adenosine transiently depresses sinus node activity and slows atrioventricular conduction and is considered safe in pregnancy and with breast feeding [1].  Adenosine deaminase, the enzyme responsible for degradation, declines in pregnancy so doses of 6-12mg are often sufficient[2].

The European Society of Cardiology 2018 guidelines categorise haemodynamically stable SVT as low risk and advise only consultation with a cardiologist and for the mode and location of delivery to be advised by obstetricians [3].

Synchronised electrical cardioversion may be necessary in SVT resistant to pharmacological therapy or haemodynamically unstable patients. It has been used in all stages of pregnancy without significant complications [4]. Transient foetal dysrhythmias have been described and CTG monitoring is advised [5].

Conclusion

We present a case of a 21 year-old developing AVNRT during the second stage of labour which responded to Adenosine 6mg. Supraventricular tachycardia’s are not uncommon in labour and often respond to pharmacological therapy. Synchronised electrical cardioversion is recommended in unstable patients as in non-pregnant women.

References

1.Pamlakhan K et al. Supraventricular arrhythmia in pregnancy. Heart. 2022; 108:1674-1681.
2.Robins K, Lyons G. Supraventricular tachycardia in pregnancy. - British Journal of Anaesthesia 2004. 92 (1), 140-143.
3.2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | European Heart Journal | Oxford Academic (oup.com)
4.Klepper I, Cardioversion late pregnancy. Anaesthesia 1981. 36, 611-616.
5.Finlay AY, Edmunds V. DC Cardioversion in pregnancy. BR J Clin Pract 1979,33,88-94.
oaa2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.